With the Covid-19 outbreak having caused significant disruption to healthcare services, including those for hepatitis C, this webinar was organised to discuss how services have been affected in Scotland and explore how hepatitis C services can most effectively be re-established as we emerge from the early phase of the outbreak. The webinar featured contributions from the following speakers:
Professor John Dillon - Clinical Lead for Blood Borne Viruses, NHS Tayside
Leon Wylie - Lead Officer, Hepatitis Scotland
Rachel Halford - CEO, The Hepatitis C Trust
Guidance on Contingency Planning for People who use Drugs and COVID-19: Version 2.0
Download
This Scottish Drugs Forum-produced guidance is aimed at those planning and designing services as well as those managing and delivering services for people who use drugs, in particular those people on opioid substitution therapy (OST) and people who inject drugs. The guidance includes a section on blood borne virus (BBV) testing, noting that "all delayed BBV results from dry blood spot tests must be proactively followed up in a timely manner once COVID-19 related restrictions allow".
